PREDICTIVE ONCOLOGY Trademark

Trademark Overview

On Tuesday, June 4, 2019, a trademark application was filed for PREDICTIVE ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the PREDICTIVE ONCOLOGY trademark a serial number of 88459018. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2020. This trademark is owned by Precision Therapeutics Inc.. The PREDICTIVE ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research services, namely, development of customized medical treatments through genetic cell analysis
predictive oncology

General Information

Serial Number88459018
Word MarkPREDICTIVE ONCOLOGY
Filing DateTuesday, June 4, 2019
Status700 - REGISTERED
Status DateTuesday, June 2, 2020
Registration Number6071356
Registration DateTuesday, June 2, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"ONCOLOGY"
Goods and ServicesMedical research services, namely, development of customized medical treatments through genetic cell analysis

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 18, 2019
Primary Code042
First Use Anywhere DateMonday, June 10, 2019
First Use In Commerce DateMonday, June 10, 2019

Trademark Owner History

Party NamePREDICTIVE ONCOLOGY INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEagan, MN 55121
Party NamePREDICTIVE ONCOLOGY INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressEAGAN, MN 55121
Party NamePrecision Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEagan, MN 55121

Trademark Events

Event DateEvent Description
Monday, July 29, 2019NON-FINAL ACTION E-MAILED
Monday, July 29, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 29, 2020TEAS AMENDMENT OF USE RECEIVED
Wednesday, January 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 7, 2019NEW APPLICATION ENTERED
Tuesday, June 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 24, 2019ASSIGNED TO EXAMINER
Monday, July 29, 2019NON-FINAL ACTION WRITTEN
Monday, February 10, 2020AMENDMENT TO USE PROCESSING COMPLETE
Monday, February 10, 2020USE AMENDMENT FILED
Monday, February 3, 2020ASSIGNED TO LIE
Monday, February 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 12, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 14, 2020USE AMENDMENT ACCEPTED
Friday, February 14, 2020NON-FINAL ACTION WRITTEN
Friday, February 14, 2020NON-FINAL ACTION E-MAILED
Friday, February 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 15, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, April 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 28, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, April 29, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 2, 2020REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, January 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 2, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

oncology predictive medical through genetic cell analysis treatments customized research services namely